We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Activotec Releases Brochure for its Activo-P11 Peptide Synthesizer

Read time: Less than a minute

Activotec has released a new brochure for its Activo-P11 Peptide Synthesizer that includes description of a host of new technical innovations that further enhance synthesis of high quality peptides.

Activotec has included many features on the Activo-P11 that benefit users. Designed by chemists for chemists, the fully automated Activo-P11 is easy to use.

To increase coupling efficiency for difficult or long sequences Activotec have introduced reactor heating on the Activo-P11. New peptide wizard software prompts users enabling definition of protocols; just enter the peptide sequence, fill in the quantity required, define the resin to use and then press run.

Cycle times as low as 30 minutes per coupling are now possible and even long peptides can be synthesized with true walk away automation. Disposable reactors and amino acid containers aid easy installation, removal and maintenance.

Combining compatibility with a wide range of commercially available resins and reagents with the ability to perform a wide range of Fmoc and t-Boc chemistries the versatile Activo-P11 peptide synthesizer is able to synthesize peptides in the 0.1 - 2.0 mmol. scale.

The new brochure also describes the Activo-P12 - a new peptide cleavage device for use with the Activo-P11 synthesizer. The Activo-P12 has been designed to directly accept the removed disposable reactor from the Activo-P11 peptide synthesizer.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.